SBH
BEAT

Segall Bryant & Hamill’s BioTelemetry, Inc. BEAT Stock Holding History

Segall Bryant & Hamill’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-14,586
Closed -$660K – 816
2020
Q2 		$660K Buy
14,586
+445
+3% +$19.9K 0.01% 533
2020
Q1 		$545K Sell
14,141
-1,584
-10% -$72.9K 0.01% 572
2019
Q4 		$729K Sell
15,725
-1,170
-7% -$50.7K 0.01% 592
2019
Q3 		$689K Buy
16,895
+67
+0.4% +$2.89K 0.01% 590
2019
Q2 		$810K Buy
16,828
+4,015
+31% +$211K 0.01% 572
2019
Q1 		$802K Sell
12,813
-10,180
-44% -$699K 0.01% 582
2018
Q4 		$1.37M Sell
22,993
-725
-3% -$43.5K 0.02% 466
2018
Q3 		$1.53M Buy
+23,718
New +$1.32M 0.02% 480

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Segall Bryant & Hamill's BEAT Position: Q3 2020 in Review

Segall Bryant & Hamill sold out of BioTelemetry, Inc. (BEAT) in Q3 2020, closing a stake of 14,586 shares — an estimated $660K sold.

Segall Bryant & Hamill first reported a position in BEAT in Q3 2018 and held it in 8 quarters. The position peaked at $1.53M in Q3 2018. 209 funds tracked by Wall St. Rank hold BEAT as of Q3 2020.

  • Segall Bryant & Hamill reported no remaining BioTelemetry, Inc. position as of Q3 2020 after selling out during the quarter.
  • Segall Bryant & Hamill sold 14,586 BioTelemetry, Inc. shares in Q3 2020, an estimated $660K.
  • Segall Bryant & Hamill first reported a position in BioTelemetry, Inc. in Q3 2018 and held it in 8 quarters.
  • Segall Bryant & Hamill's BioTelemetry, Inc. position peaked at $1.53M in Q3 2018.
  • 209 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2020.

Based on Segall Bryant & Hamill's 13F filing for Q3 2020, filed 13 Nov 2020.